These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 26757139)

  • 21. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.
    Rochtus A; Olson HE; Smith L; Keith LG; El Achkar C; Taylor A; Mahida S; Park M; Kelly M; Shain C; Rockowitz S; Rosen Sheidley B; Poduri A
    Epilepsia; 2020 Feb; 61(2):249-258. PubMed ID: 31957018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel variants underlying autosomal recessive intellectual disability in Pakistani consanguineous families.
    Ilyas M; Efthymiou S; Salpietro V; Noureen N; Zafar F; Rauf S; Mir A; Houlden H
    BMC Med Genet; 2020 Mar; 21(1):59. PubMed ID: 32209057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability.
    Benson KA; White M; Allen NM; Byrne S; Carton R; Comerford E; Costello D; Doherty C; Dunleavey B; El-Naggar H; Gangadharan N; Heavin S; Kearney H; Lench NJ; Lynch J; McCormack M; Regan MO; Podesta K; Power K; Rogers AS; Steward CA; Sweeney B; Webb D; Fitzsimons M; Greally M; Delanty N; Cavalleri GL
    Eur J Hum Genet; 2020 Aug; 28(8):1066-1077. PubMed ID: 32238909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability.
    Brea-Fernández AJ; Álvarez-Barona M; Amigo J; Tubío-Fungueiriño M; Caamaño P; Fernández-Prieto M; Barros F; De Rubeis S; Buxbaum J; Carracedo Á
    Eur J Hum Genet; 2022 Aug; 30(8):938-945. PubMed ID: 35322241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-exome sequencing is a powerful approach for establishing the etiological diagnosis in patients with intellectual disability and microcephaly.
    Rump P; Jazayeri O; van Dijk-Bos KK; Johansson LF; van Essen AJ; Verheij JB; Veenstra-Knol HE; Redeker EJ; Mannens MM; Swertz MA; Alizadeh BZ; van Ravenswaaij-Arts CM; Sinke RJ; Sikkema-Raddatz B
    BMC Med Genomics; 2016 Feb; 9():7. PubMed ID: 26846091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis.
    Nambot S; Thevenon J; Kuentz P; Duffourd Y; Tisserant E; Bruel AL; Mosca-Boidron AL; Masurel-Paulet A; Lehalle D; Jean-Marçais N; Lefebvre M; Vabres P; El Chehadeh-Djebbar S; Philippe C; Tran Mau-Them F; St-Onge J; Jouan T; Chevarin M; Poé C; Carmignac V; Vitobello A; Callier P; Rivière JB; Faivre L; Thauvin-Robinet C;
    Genet Med; 2018 Jun; 20(6):645-654. PubMed ID: 29095811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.
    Pode-Shakked B; Barel O; Singer A; Regev M; Poran H; Eliyahu A; Finezilber Y; Segev M; Berkenstadt M; Yonath H; Reznik-Wolf H; Gazit Y; Chorin O; Heimer G; Gabis LV; Tzadok M; Nissenkorn A; Bar-Yosef O; Zohar-Dayan E; Ben-Zeev B; Mor N; Kol N; Nayshool O; Shimshoviz N; Bar-Joseph I; Marek-Yagel D; Javasky E; Einy R; Gal M; Grinshpun-Cohen J; Shohat M; Dominissini D; Raas-Rothschild A; Rechavi G; Pras E; Greenbaum L
    Sci Rep; 2021 Sep; 11(1):19099. PubMed ID: 34580403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
    Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA
    Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
    Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
    Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marked yield of re-evaluating phenotype and exome/target sequencing data in 33 individuals with intellectual disabilities.
    Xiao B; Qiu W; Ji X; Liu X; Huang Z; Liu H; Fan Y; Xu Y; Liu Y; Yie H; Wei W; Yan H; Gong Z; Shen L; Sun Y
    Am J Med Genet A; 2018 Jan; 176(1):107-115. PubMed ID: 29159939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of clinical exome sequencing in the diagnostic procedure of patients with intellectual disability in clinical practice.
    Ballesta-Martínez MJ; Pérez-Fernández V; López-González V; Sánchez-Soler MJ; Serrano-Antón AT; Rodríguez-Peña LI; Barreda-Sánchez M; Armengol-Dulcet L; Guillén-Navarro E
    Orphanet J Rare Dis; 2023 Jul; 18(1):201. PubMed ID: 37480025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-Generation Sequencing in Unexplained Intellectual Disability.
    Sandal S; Verma IC; Mahay SB; Dubey S; Sabharwal RK; Kulshrestha S; Saxena R; Suman P; Kumar P; Puri RD
    Indian J Pediatr; 2024 Jul; 91(7):682-695. PubMed ID: 37804371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulating whole exome sequencing as a diagnostic test.
    Lapin V; Mighion LC; da Silva CP; Cuperus Y; Bean LJ; Hegde MR
    Hum Genet; 2016 Jun; 135(6):655-73. PubMed ID: 27167135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic yield of genetic and metabolic investigations in syndromic and nonsyndromic patients with autism spectrum disorder, global developmental delay, or intellectual disability from a dedicated neurodevelopmental disorders genetics clinic.
    Postma JK; Harrison MA; Kutcher S; Webster RJ; Cloutier M; Bourque DK; Yu AC; Carter MT
    Am J Med Genet A; 2024 Nov; 194(11):e63791. PubMed ID: 39031819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genetic causes in children with unexplained epilepsy based on trio-whole exome sequencing.
    Chengyan L; Chupeng X; You W; Yinhui C; Binglong H; Dang A; Ling L; Chuan T
    Clin Genet; 2024 Aug; 106(2):140-149. PubMed ID: 38468460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort.
    Dias KR; Shrestha R; Schofield D; Evans CA; O'Heir E; Zhu Y; Zhang F; Standen K; Weisburd B; Stenton SL; Sanchis-Juan A; Brand H; Talkowski ME; Ma A; Ghedia S; Wilson M; Sandaradura SA; Smith J; Kamien B; Turner A; Bakshi M; Adès LC; Mowat D; Regan M; McGillivray G; Savarirayan R; White SM; Tan TY; Stark Z; Brown NJ; Pérez-Jurado LA; Krzesinski E; Hunter MF; Akesson L; Fennell AP; Yeung A; Boughtwood T; Ewans LJ; Kerkhof J; Lucas C; Carey L; French H; Rapadas M; Stevanovski I; Deveson IW; Cliffe C; Elakis G; Kirk EP; Dudding-Byth T; Fletcher J; Walsh R; Corbett MA; Kroes T; Gecz J; Meldrum C; Cliffe S; Wall M; Lunke S; North K; Amor DJ; Field M; Sadikovic B; Buckley MF; O'Donnell-Luria A; Roscioli T
    Genet Med; 2024 May; 26(5):101076. PubMed ID: 38258669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proband-Only Clinical Exome Sequencing for Neurodevelopmental Disabilities.
    Kim SH; Kim B; Lee JS; Kim HD; Choi JR; Lee ST; Kang HC
    Pediatr Neurol; 2019 Oct; 99():47-54. PubMed ID: 30952489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo variants in neurodevelopmental disorders with epilepsy.
    Heyne HO; Singh T; Stamberger H; Abou Jamra R; Caglayan H; Craiu D; De Jonghe P; Guerrini R; Helbig KL; Koeleman BPC; Kosmicki JA; Linnankivi T; May P; Muhle H; Møller RS; Neubauer BA; Palotie A; Pendziwiat M; Striano P; Tang S; Wu S; ; Poduri A; Weber YG; Weckhuysen S; Sisodiya SM; Daly MJ; Helbig I; Lal D; Lemke JR
    Nat Genet; 2018 Jul; 50(7):1048-1053. PubMed ID: 29942082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.